Knyszyńska, Anna, Radecka, Aleksandra, Zabielska, Paulina et al. · International journal of environmental research and public health · 2020 · DOI
This study looked at whether iron levels in the blood are connected to fatigue, depression, and quality of life in people with multiple sclerosis (MS). Researchers tested blood samples from 90 MS patients and found that people with lower iron storage (ferritin) levels tended to have worse depression and lower quality of life. The study suggests that iron deficiency might play a role in how MS patients experience fatigue and mood problems.
ME/CFS and MS share overlapping symptoms of chronic fatigue and depression that significantly impair function. This study provides preliminary evidence that iron metabolism may be a treatable biomarker linked to mood and quality-of-life outcomes, potentially opening new avenues for targeted intervention in ME/CFS populations with similar metabolic dysregulation.
This study does not prove that iron deficiency *causes* depression or reduced quality of life in MS—only that they are associated. The cross-sectional design cannot establish temporal relationships or determine whether iron deficiency is a primary driver versus a consequence of other disease processes. Whether these findings apply to ME/CFS patients remains unknown.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →